Compounds > tezosentan
Page last updated: 2024-09-04

tezosentan and Hepatorenal Syndrome

tezosentan has been researched along with Hepatorenal Syndrome in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baumelou, A; Izzedine, H1
Dingemanse, J; Jalan, R; Moore, K; Wong, F1

Trials

1 trial(s) available for tezosentan and Hepatorenal Syndrome

ArticleYear
Lack of renal improvement with nonselective endothelin antagonism with tezosentan in type 2 hepatorenal syndrome.
    Hepatology (Baltimore, Md.), 2008, Volume: 47, Issue:1

    Topics: Endothelin-1; Hemodynamics; Hepatorenal Syndrome; Humans; Kidney; Kidney Function Tests; Liver Cirrhosis; Male; Middle Aged; Pilot Projects; Pyridines; Sodium; Tetrazoles; Treatment Failure; Water

2008

Other Studies

1 other study(ies) available for tezosentan and Hepatorenal Syndrome

ArticleYear
Renal failure in cirrhosis.
    The New England journal of medicine, 2010, Jan-07, Volume: 362, Issue:1

    Topics: Bosentan; Endothelin Receptor Antagonists; Endothelins; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Pyridines; Renal Insufficiency; Sulfonamides; Tetrazoles

2010